SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-014264
Filing Date
2019-08-01
Accepted
2019-08-01 06:15:17
Documents
4
Period of Report
2019-08-01

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k080119_alteritytherap.htm 6-K 13758
2 APPENDIX 3B f6k080119ex99-1_alterity.htm EX-99.1 128335
3 GRAPHIC apedixb_001.jpg GRAPHIC 4788
4 GRAPHIC apedixb_002.jpg GRAPHIC 1342
  Complete submission text file 0001213900-19-014264.txt   151916
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 19990780
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1